SCHEMBL8364951

SCHEMBL8364951

COC(=O)/C(=C/c1cccc(Br)c1)NC(=O)OCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
HCAR2 Q8TDS4 1/20 0.43
GLA P06280 1/20 0.41
HTT P42858 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MGLL Q99685 1/20 0.40
PLAAT5 Q96KN8 1/20 0.40
PLAAT4 Q9UL19 1/20 0.40
AAK1 Q2M2I8 2/20 0.40
LMNA P02545 2/20 0.40
USP2 O75604 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
RECQL P46063 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8366226 1.00 MEN1 (0.43) MEN1KMT2AHCAR2GLAHTT
SCHEMBL14623158 0.90 MMP1 (0.43) MEN1KMT2AMGLLLMNACA12
SCHEMBL13906649 0.88 CA12 (0.47) MEN1KMT2AHTTLMNACA12
SCHEMBL28781880 0.86 HCAR2 (0.43) MEN1KMT2AHCAR2HTTL3MBTL1
SCHEMBL5893113 0.84 MEN1 (0.43) MEN1KMT2AHTTL3MBTL1AAK1
SCHEMBL10129718 0.84 CA1 (0.43) MEN1KMT2AHTTMGLLLMNA
SCHEMBL13409451 0.81 MGLL (0.42) MEN1KMT2AMGLLLMNACA12
SCHEMBL2970560 0.81 BACE1 (0.41) MEN1KMT2AL3MBTL1LMNACA12
SCHEMBL2970563 0.81 BACE1 (0.41) MEN1KMT2AL3MBTL1LMNACA12
SCHEMBL2970566 0.81 BACE1 (0.41) MEN1KMT2AL3MBTL1LMNACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080096942-A1 Substituted Hydroxyethylamines ELAN PHARMACEUTICALS, INC. 2008-04-24 US disclosed
US-20080096942-A1 Substituted Hydroxyethylamines ELAN PHARMACEUTICALS, INC. 2008-04-24 US disclosed
US-7312360-B2 Substituted hydroxyethylamines ELAN PHARMACEUTICALS, INC. (US) 2007-12-25 US disclosed
US-7312360-B2 Substituted hydroxyethylamines ELAN PHARMACEUTICALS, INC. (US) 2007-12-25 US disclosed
WO-2003050073-A1 SUBSTITUTED HYDROXYETHYLAMINES ELAN PHARMACEUTICALS, INC. (US) 2003-06-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096942-A1 Substituted Hydroxyethylamines BACE1, BACE2, MME MEN1 2994/4885KMT2A 528/4885HCAR2 364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.